• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Delivering Better Gut Health Supplements

    Delivering Dietary Supplements that Exceed Consumer Expectations

    Green Business Network Seeks Comment on New Certification for Hemp-CBD Businesses

    Sweeteners Market Continues to Broaden with Cleaner Labels and Better Formulations

    Optimizing Gut Health: Unlocking the Gates to Well-Being
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval

    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits

    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress

    Arla Foods Enters New Partnership to Reduce Malnutrition With Dried Papaya Snack

    Metabolaid Botanical Extract Evidenced to Reduce Blood Pressure
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval

    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits

    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress

    Arla Foods Enters New Partnership to Reduce Malnutrition With Dried Papaya Snack

    Metabolaid Botanical Extract Evidenced to Reduce Blood Pressure
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval

    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits

    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress

    Arla Foods Enters New Partnership to Reduce Malnutrition With Dried Papaya Snack

    Metabolaid Botanical Extract Evidenced to Reduce Blood Pressure
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval

    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits

    Metabolaid Botanical Extract Evidenced to Reduce Blood Pressure

    Study Finds People With Obesity are More Responsive To Food Marketing – Until Their Weight Drops

    Four-Week Fish Oil Regimen Showed Significant Muscular Damage Protection in Recent Study
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    AIDP

    Xsto Solutions

    Bioenergy Life Science, Inc. (BLS)

    Gencor

    Chenland Nutritionals Inc.
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    AIDP

    Xsto Solutions

    Gencor

    Indena USA, Inc.

    Verdure Sciences
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Should Practitioners Have a Role In Rewriting DSHEA?

    Medical opinion leaders can become valuable allies in the coming contentions over supplement regulations.

    Should Practitioners Have a Role In Rewriting DSHEA?
    Critical voices are getting stronger.
    Related CONTENT
    • Standard Process Partners with BIOHM Health to Deliver Microbiome Test Kit
    • Federal Regulators Slam Doctors for COVID-Related Communications
    • Are We at The End of the ‘Integrative Medicine’ Era?
    • Healthcare Under Trump: What Can the Practitioner Channel Expect?
    • In the Post-Election Lull, Cultivate Clinical Allies
    Erik Goldman, Holistic Primary Care10.01.15
    It is becoming apparent that—like it or not—the dietary supplements industry will face significant regulatory changes in the not-too-distant future.

    A perfect storm of declining retail sales, eroding consumer trust, high-profile regulatory action by state attorneys general, attrition of the industry’s political allies, and increased scrutiny by high-profile critics is forcing the industry to recognize that the Dietary Supplement Health and Education Act (DSHEA) may be reaching the limit of its utility.

    What a revised regulatory framework would look like, and who would be involved in the revising, is anybody’s guess at this point.
    But in recent months, key players in the field have been floating the previously unthinkable notion that DSHEA needs an overhaul. 
    Industry leaders, including United Natural Products Alliance President Loren Israelsen—one of the original architects and champions of DSHEA—are calling on the industry’s brain trust to take a proactive role in defining what “DSHEA 2.0” ought to be.

    The prevailing view is that if industry does not come forward with a new vision for more effective regulation, unfriendly legislators will do so in the next few years, and the industry won’t like the way it fits. 

    Facing the Critics
    For the first time, industry leaders seem willing to reckon with outspoken critics like Sen. Dick Durbin, who has publicly demanded that the industry—and those charged with regulating it—do a better job of guaranteeing that:

    1) What is on a product’s label is actually in the bottle.
    2) Consumer safety is assured when a product is used as directed.
    3) There is meaningful science supporting a product’s claims.
    4) There is traceability and transparency in manufacture.

    The critical voices are only getting stronger, and unfortunately, one need not look too hard to find companies within our gates that are flagrantly defying reasonable standards of business ethics, to say nothing of GMPs.

    As a first step in demonstrating proactivity on the regulatory front, Mr. Israelsen’s group, along with the Consumer Healthcare Products Association (CHPA), the Council for Responsible Nutrition (CRN) and the Natural Products Association (NPA), issued a joint letter to the Food and Drug Administration urging the agency to elevate its Division of Dietary Supplement Programs to the status of “Office,” and to fund it accordingly.

    This, the trade groups said, would, “enhance the effectiveness of dietary supplement regulation by allowing this new Office to better compete for resources and attention within the Agency,” and “could help to increase FDA’s abilities to take more aggressive enforcement action” against companies marketing spiked or adulterated supplements.

    UNPA and other groups have also supported a recent citizen’s petition forwarded by the Organic and Natural Health Association requesting that FDA extend GMP compliance requirements to include raw materials suppliers.

    Such steps are good as far as they go, in that they do demonstrate the industry’s willingness to engage constructively with regulators. But this is low-hanging fruit. Deconstructing and redesigning DSHEA is another matter.

    Some thought leaders looking into this believe that fundamentally, the DSHEA framework is sound, and with a little tweaking and more thorough enforcement the law would be fit for purpose for years to come.

    Others hold that DSHEA needs a top-to-bottom overhaul, and that the entire premise of structure-function claims needs to be re-thought.

    It remains to be seen which approach the industry ultimately takes, and how the industry’s vision jibes with that of legislators.

    Engaging Clinicians
    My sincere hope is that industry leaders bring physicians and other healthcare practitioners into the dialogue, and that the needs and concerns of medical professionals are included in any serious discussion about regulatory revision.

    Clinicians had very little to do with the development of DSHEA and with the implementation of regulations governing supplements and natural products. That’s totally understandable.

    Twenty-plus years ago, when the law was written, few healthcare professionals used supplements in their practices. Those who did were largely outside the mainstream and for the most part, they were comfortable in the margins.

    Likewise, in the early 1990s there were only a handful of nutraceutical companies playing to practitioners—primarily chiropractors and naturopaths. Some of those companies (think Standard Process) actually had long historical legacies dating back to the earliest days of the nutrition industry. But, like the practitioners they served, most were well below the radar of conventional medicine.

    In short, there was no such thing as the Practitioner Channel for dietary supplements back in the early 1990s.

    While there were a number of outspoken nutra-friendly doctors who added their voices to the swell of consumer advocacy supporting DSHEA, practitioner involvement did not go much beyond that.

    Honestly, I’d hazard a bet that even today, many practitioners do not really know what DSHEA is about.

    That’s problematic, because the rules established under DSHEA have very specific implications for practitioner channel brands, and for the practitioners themselves.

    Strictures on Science
    For one, because DSHEA only permits structure/function claims, it imposes severe restrictions on the scope of clinical research on vitamins, herbs and other types of supplements.

    Simply put, the law makes it difficult in the U.S. to study supplements in people with diseases.

    In the eyes of the regulators, a trial designed to assess a supplement as a potential treatment for a disease is, de facto, a disease claim. And that, as we all know, is prohibited by DSHEA.

    This means U.S. studies of supplements can only enroll healthy people, and that makes it very hard to show a meaningful effect size. Give painkillers to people without pain and you’re not likely to see a measurable effect.

    There are many examples of studies that do show specific supplements might mitigate specific disease states. But these are based either on epidemiological correlations or on changes in biomarkers and other indirect disease indicators—a regulatory gray area with ever-changing boundary lines.

    Trials looking at supplements as treatments for various diseases do exist, but they’re almost always done outside the U.S.

    In all these cases, it is easy for U.S. doctors to dismiss evidence: epidemiological correlations are not considered “gold standard” data; biomarkers can be easily challenged as irrelevant; and data from other countries is, well, foreign.

    In aggregate, the research restrictions imposed by DSHEA contribute to a general sense often voiced by doctors that there’s little research to support supplements, and that the research that does exist is vague or flimsy.

    Even when research is solid and significant, it often comes out sounding like flim-flam once it goes through the structure/function transducer.

    The reality is that medical practitioners see sick people and they treat or try to prevent diseases. They don’t think of their work as “supporting healthy function.” It is a major challenge for marketers to get their messages across in terms that physicians understand but don’t run afoul of DSHEA.

    All of this adds up to a perception among some healthcare professionals that the supplement industry is less-than-honest.

    The robust growth of the practitioner channel—generating more than $3 billion annually, and rising at a steady 7-8% per year despite these restrictions and the major retail downturns—is a testament to the value of many supplement products, the commitment of practitioner channel brands, and the open-mindedness of a growing number of clinicians.

    Practitioners deeply engaged in natural medicine and who use many supplements generally understand the restrictions DSHEA imposes, and they can read through the language-games. Other practitioners, including those who guard the gates of the major academic medical centers and the managed care plans, are less familiar with the regulations and less forgiving of the double-speak.

    Practitioner Views on Regulation
    Holistic Primary Care’s 2015 Practitioner Survey, which gathered data from more than 650 primary care physicians, 125 specialists and 90+ nurses, included questions gauging practitioner attitudes toward regulation.

    While 17% of the primary care respondents felt that the existing system is adequate to ensure the quality and safety of supplements, and 48% agreed that existing regulations would be adequate if properly enforced, 35% believed that a total regulatory overhaul is needed.

    The latter position was particularly strong among MDs (compared with NDs, DCs and other non-MDs) and among those in insurance-based versus insurance-free practices. It is important to note that these survey respondents were generally friendly toward nutritional medicine and supplements.

    Verbatim comments in response to the regulatory questions revealed that while these clinicians see the value of supplements in their practices, they are also mistrustful of industry and of regulators alike.

    As one primary care doctor put it: “Quality control needs to be implemented and enforced, but not by the FDA, who have an anti-nutrition stance.”

    Others hold that the existing regulatory system has not been able to prevent a flood of questionable products making dubious claims and lacking quality control. This can make it difficult for them—and for their patients—to feel secure knowing they are purchasing safe and effective supplements. Still others echo the oft-heard view that the nutrition industry is entirely unregulated.

    An Opportunity for Evolution
    In the 20 years since passage of DSHEA, the supplement industry has experienced remarkable growth, and some of the strongest and most consistent growth has been in the practitioner channel. Clearly many more medical professionals have become interested in supplements, and have begun using them in their practices.

    Mainstream institutions that once scoffed at the very notion that nutrition was part of “real” medicine, are championing functional medicine and lifestyle change as the keys to a healthy future. For the most part, the industry as a whole has done little to cultivate allies within healthcare, and to develop stronger relationships with the medical community.

    Beyond feeding on the retail buzz generated by high-profile media medicos like Mehmet Oz, Mark Hyman and David Perlmutter, and beyond support of conferences and educational events in the holistic/functional medicine space, the industry has not done much to engage practitioners in the broader issues.

    I believe practitioner channel companies need to take a lead role in the process of revising and redefining the regulations, and they need to engage practitioners in that process.

    Because they are playing in the healthcare arena, practitioner-focused brands have a greater stake in science, and a stronger imperative for maintaining the highest standards of quality in manufacture, and the highest ethical standards in marketing.

    Pro lines should be setting the quality bar for the industry as a whole, and should be willing to stand up—and stand out—as examples of how to combine innovation with integrity.

    They are also in the best position to create meaningful relationships with physicians, nurses and other healthcare stakeholders, and to identify common ground between the industry and the practitioner groups that are reshaping how medicine is practiced in this country.

    These relationships will be extremely important for the future of the practitioner channel specifically, but also for the industry as a whole.

    Medical opinion leaders who understand what the industry has to offer and who recognize the constrictions under which the industry has had to operate can become valuable allies in the coming contentions over supplement regulations.

    It’s not about identifying which clinician might be the “next Dr. Oz.” It’s about engaging prominent as well as unknown practitioners, as well as practitioner groups, in the discourse about regulation and the role of supplements in healthcare at large.

    The industry has plenty of critics within the ranks of healthcare. It is high time to invest in cultivating medical allies.


    Erik Goldman
    Holistic Primary Care

    Erik Goldman is co-founder and editor of Holistic Primary Care: News for Health & Healing, a quarterly medical publication reaching about 60,000 physicians and other healthcare professionals nationwide. He is also co-producer of the Practitioner Channel Forum, April 6-8, 2016, at the Marriott Coronado Island in San Diego. The Forum is the nation’s leading conference focused on opportunities and challenges in the practitioner segment of the dietary supplement industry. A comprehensive 48-page Executive Summary of findings from Holistic Primary Care’s 2015 survey of primary care practitioners, as well as five categories of medical specialists, is available for purchase at http://tpcforum.com/physician-survey.
    Related Searches
    • Nutritional
    • Adulterated
    • chpa
    • Nutraceutical
    Related Knowledge Center
    • Vitamins
    • Regulations
    • Dietary Supplements
    Suggested For You
    Standard Process Partners with BIOHM Health to Deliver Microbiome Test Kit Standard Process Partners with BIOHM Health to Deliver Microbiome Test Kit
    Federal Regulators Slam Doctors for COVID-Related Communications Federal Regulators Slam Doctors for COVID-Related Communications
    Are We at The End of the ‘Integrative Medicine’ Era? Are We at The End of the ‘Integrative Medicine’ Era?
    Healthcare Under Trump: What Can the Practitioner Channel Expect? Healthcare Under Trump: What Can the Practitioner Channel Expect?
    In the Post-Election Lull, Cultivate Clinical Allies In the Post-Election Lull, Cultivate Clinical Allies
    FDA’s NDI Draft Guidance: What Insiders Need to Know FDA’s NDI Draft Guidance: What Insiders Need to Know
    The Regulatory Drumbeat Continues to Echo The Regulatory Drumbeat Continues to Echo
    The Millennials Are Coming … And They’re Changing Healthcare The Millennials Are Coming … And They’re Changing Healthcare
    Should Practitioner-Channel Brands Make Peace With Amazon? Should Practitioner-Channel Brands Make Peace With Amazon?
    The DSHEA Disconnect: What Doctors Don’t Know Can Hurt Us The DSHEA Disconnect: What Doctors Don’t Know Can Hurt Us
    Trade Associations Seek Elevation of FDA’s Supplement Division to ‘Office’ Trade Associations Seek Elevation of FDA’s Supplement Division to ‘Office’
    State of the Industry Review & Outlook for 2016 State of the Industry Review & Outlook for 2016
    Trade Organizations Urge FDA to Create Separate Division of Dietary Supplements Trade Organizations Urge FDA to Create Separate Division of Dietary Supplements
    Jeff Hilton to Present Workshop at Practitioner Channel Forum Jeff Hilton to Present Workshop at Practitioner Channel Forum
    Holistic Primary Care Presents 3rd Annual Practitioner Channel Forum Holistic Primary Care Presents 3rd Annual Practitioner Channel Forum

    Related Columns

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      Medically Necessary Foods: Pricing & Reimbursement Considerations

      Medically Necessary Foods: Pricing & Reimbursement Considerations

      Navigating the large and growing medical foods market requires understanding key dynamics.
      By Gregory Stephens, Windrose Partners 04.08.21

    • Dietary Supplements | Regulations
      Dual Tracking of New Ingredients as Dietary Supplements and Drugs

      Dual Tracking of New Ingredients as Dietary Supplements and Drugs

      It’s possible to develop novel ingredients for both the dietary supplement and drug markets, but timing is important and there are gray areas.
      By Todd Harrison, Venable 04.08.21

    • Dietary Supplements | Probiotics & Prebiotics | Regulations | World Markets
      Probiotics & Prebiotics: The EU Ban is Shaking

      Probiotics & Prebiotics: The EU Ban is Shaking

      Some countries have not accepted the European Commission’s limitations on the term ‘probiotic’ and have implemented their own interpretations.
      By Joerg Gruenwald, analyze & realize ag 04.08.21


    • Dietary Supplements | Healthcare Trends | Immune Function | Medical Nutrition | Vitamins
      Biden COVID Response Plan Overlooks Nutrition

      Biden COVID Response Plan Overlooks Nutrition

      Our field has a unique opportunity to demonstrate the merits of our products, and the principles and philosophies behind them.
      By Erik Goldman, Holistic Primary Care 03.03.21

    • Consumer Trends | Dietary Supplements | Herbs & Botanicals | Quality & Safety
      Open Book Extracts: Innovating for Tomorrow’s Market

      Open Book Extracts: Innovating for Tomorrow’s Market

      Dave Neundorfer has a clear vision to deliver pure and consistent cannabinoids for a range of product types.
      By Sheldon Baker 03.03.21

    • Consumer Trends | Dietary Supplements | Herbs & Botanicals | Regulations
      The Evolution of Insurance for Hemp & CBD

      The Evolution of Insurance for Hemp & CBD

      Delta-8-THC is the latest wrinkle in the hemp-derived products market.
      By Chris Morey, Bolton & Company 03.03.21


    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      The Off-Label On Ramp

      The Off-Label On Ramp

      With an expanding base of clinical research supporting nutritional interventions, off label use of dietary supplements and medical foods is likely to grow.
      By Gregory Stephens, Windrose Partners, and Sheila Campbell, PhD, RD 01.19.21

    • Dietary Supplements | Healthcare Trends | Immune Function | Regulations
      ‘Follow the Science’ Often Misses the Mark with Nutrition

      ‘Follow the Science’ Often Misses the Mark with Nutrition

      The mantra too often ignores common sense approaches to improving health and quality of life.
      By Todd Harrison, Venable 01.19.21

    • Dietary Supplements | Herbs & Botanicals | Regulations | World Markets
      CBD in Europe: News from the Front

      CBD in Europe: News from the Front

      A recent decision by the Court of Justice of the European Union has restored CBD’s status, and with it, the prospects of the entire industry.
      By Joerg Gruenwald, analyze & realize ag 01.19.21


    • Delivery & Dosage Technologies | Dietary Supplements | Herbs & Botanicals | Quality & Safety
      The Advantages of Organic, Broad Spectrum Hemp

      The Advantages of Organic, Broad Spectrum Hemp

      Mike Hennesy, Wana Brands, discusses the company’s new gummies, innovation, and continuing market evolution.
      By Sheldon Baker 12.04.20

    • Dietary Supplements | Regulations
      Insurance Rates Have Been at an All-Time Low, But a Hard Market is Coming

      Insurance Rates Have Been at an All-Time Low, But a Hard Market is Coming

      Companies can be prepared by being thorough and transparent while going through insurance policy renewals.
      By Chris Morey, Bolton & Company 12.04.20

    • Dietary Supplements | Regulations
      A Business Perspective on Protecting Confidential Information: The NDA

      A Business Perspective on Protecting Confidential Information: The NDA

      Along with taking precautions in providing access to confidential information, a non-disclosure agreement can be a great way to protect your business.
      By Gregory Stephens, Windrose Partners 11.09.20


    • Dietary Supplements | Healthcare Trends | Immune Function | Regulations | Research | Vitamins
      Using All the Tools to Improve Public Health

      Using All the Tools to Improve Public Health

      Industry needs to make a stand in compelling authorities to communicate the value of nutrition and dietary supplementation.
      By Todd Harrison, Venable 11.09.20

    • Dietary Supplements | Regulations | World Markets
      Regulation Changes Calculus for Substance-Based Medical Devices

      Regulation Changes Calculus for Substance-Based Medical Devices

      The new regulation introduces more specific requirements for the technical documentation of this class of products.
      By Joerg Gruenwald, analyze & realize ag 11.09.20

    • Dietary Supplements | Healthcare Trends | Immune Function | Regulations
      Federal Regulators Slam Doctors for COVID-Related Communications

      Federal Regulators Slam Doctors for COVID-Related Communications

      Some practitioners were not selling or promoting products, they were simply suggesting certain natural substances might offer benefits in improving resilience.
      By Erik Goldman, Holistic Primary Care 10.01.20

    Trending
    • CGA-7 Green Coffee Extract By Vidya Herbs Achieves Self-Affirmed GRAS Status
    • Review Covers Role Of Vitamin K2 In The ‘Calcium Paradox’
    • Several Studies Evaluate Role Of Vitamin D In COVID-19 Outcomes
    • BIO-CAT Microbials’ OPTI-BIOME Probiotic Strain Receives FDA 'Letter Of No Objection' On GRAS Status
    • Meta-analysis Determines HMB Supplementation Promotes Healthy Muscle Mass In Older Adults
    Breaking News
    • AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    • Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    • FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress
    • Arla Foods Enters New Partnership to Reduce Malnutrition With Dried Papaya Snack
    • Metabolaid Botanical Extract Evidenced to Reduce Blood Pressure
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Optimizing Gut Health: Unlocking the Gates to Well-Being
    • Sweeteners Market Continues to Broaden with Cleaner Labels and Better Formulations
    • Green Business Network Seeks Comment on New Certification for Hemp-CBD Businesses
    • Delivering Dietary Supplements that Exceed Consumer Expectations
    • Delivering Better Gut Health Supplements
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    AstaReal Astaxanthin Ingredient Receives U.S. Patent Approval
    Study on Kemin’s DailyZz Botanical Blend Uncovers Sleep Quality, Next-Day Performance Benefits
    FDA’s Dr. Cara Welch Opening Speaker at the 9th AHPA Botanical Congress
    Coatings World

    Latest Breaking News From Coatings World

    Jebsen & Jessen, Innospec Sign Distribution Agreement
    IGL Coatings Announces Partnership in Finland
    Axalta Schedules 1Q 2021 Earnings Conference Call
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Iterative Scopes Announces IBD-Focused Scientific Advisory Board
    Vicarious Surgical, D8 Holdings Corp. Combine Operations in $1.1 Billion Deal
    FDA Grants De Novo Clearance to Medtronic’s GI Genius Model
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bristol Myers Squibb Expands at Cambridge Crossing
    Amgen Completes Five Prime Acquisition
    Sartorius Expands in the UK
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Former L’Oréal Exec Joins Glossier
    Lancôme Reveals New Global Sustainability Program
    First-Ever Skincare Line Focuses on Iron To Prevent Aging
    Happi

    Latest Breaking News From Happi

    Fragrance Creators Association Celebrates P&G Executive
    Jeen International Celebrates Its 25th Anniversary
    Jeffree Star Hospitalized After Car Crash
    Ink World

    Latest Breaking News From Ink World

    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    SE-DA Invests in Kornit Presto S
    Acrylic Resins Market Worth $21.9 Billion by 2025: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI reveals Eugene Singer Award winners at Virtual Spring Summit
    Monadnock Paper Mills joins SGP
    ACTEGA helps converter reach sustainability goals
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Albaad to Add Natural-Based Line in Israel
    First Quality to Discontinue Tampon Operations
    Jessup Installs New Era Coating and Laminating Line
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    BioMagnetic Sciences Names President and CEO
    Mainstay Medical Launches ReActiv8 in Australia
    Biogennix Rolls Out Agilon Strip Bone Graft
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Virtual ASMC 2021 Spotlights Advanced Semiconductor Manufacturing Excellence
    LG Display Cuts Down CO2-eq Emissions by 3 Million Tons in 2020
    European Commission's Innovation Radar Acknowledges 3 ARMOR Innovations

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login